Dexmedetomidine for Invasive Ventilation In the NEOnate | MicrobiomeTrials← Back to trialsNCT07493785
Dexmedetomidine for Invasive Ventilation In the NEOnate
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2027-01-01Est. Completion: 2033-01-01
Enrollment target: 246 participants Locations- CHU Brest - Hôpital Morvan, Brest, France
- Centre Hospitalier Intercommunal de Créteil, Créteil, France
- CHU Grenoble Alpes, Grenoble, France
- CHRU Lille, Lille, France
- CHU Limoges, Limoges, France
- CHU de Nantes, Nantes, France
- CHU de Nice, Nice, France
- AP-HP Hôpital Necker Enfants Malades, Paris, France
- Hôpital NOVO - Site de Pontoise, Pontoise, France
- Centre Hospitalier de Saint -Denis, Saint-Denis, France
- CHU Félix Guyon (Saint Denis), Saint-Denis, France
- CHU de La Réunion - Site Sud Saint-Pierre, Saint-Pierre, France
Other microbiome trials you might be interested in
ARDS (Moderate or Severe)
To verify whether the transpulmonary pressure-guided mechanical ventilation strategy can reduce right ventricular involv…
Beijing, ChinaEst. completion Mar 31, 2028
PainNormal PhysiologyHealthy Volunteers
Background:
\- Painful stimuli cause changes in a network of brain regions called the "Pain Matrix." But most of these …
Bethesda, United StatesEst. completion Feb 20, 2027
Ventilator Associated Pneumonia
Ventilator-Associated Pneumonia (VAP) is a bacterial respiratory infection that patients in the Intensive Care Unit (ICU…
Tirana, AlbaniaEst. completion Dec 1, 2026